Free and nanoemulsified Cymbopogon flexuosus essential oil: in vitro antifungal effect on Candida spp.
DOI:
https://doi.org/10.17058/reci.v15i4.20350Keywords:
Cymbopogon, Nanoparticles, PhytochemicalsAbstract
Justification and Objectives: The Cymbopogon genus has attracted interest due to its bioactive compounds with antifungal and antimicrobial potential. This study investigated the in vitro antifungal activity of free and nanoemulsified essential oil of Cymbopogon flexuosus against ATCC standard strains of Candida spp. Methods: Candida albicans, Candida tropicalis, Candida krusei, and Candida glabrata were used in the assay, being tested alongside a positive control (fluconazole and amphotericin B) and a negative control (distilled water + 80 2% Tween). Agar diffusion was used. After treatment, the assays were incubated at 36 °C for 48 hours = in six replicates. Results: Antifungal activity was observed against all ATCC strains tested. The free oil at 10%, 15%, and 70% concentrations showed an activity similar to the positive control for C. tropicalis. The nanoemulsified oil at a 5% concentration showed results similar to the positive control for C. glabrata. Conclusion: Among the tested species, C. albicans proved to be the most sensitive at all concentrations, whereas C. krusei resisted the essential oil treatment the most. Complementing our findings requires further toxicological and clinical studies.
Downloads
References
1. Denning DW, Kneale M, D Sobel JD et al. Global burden of recurrent vulvovaginal candidiasis: a systematic review. The Lancet Infectious Diseases. 2018;18:e339–e347. DOI: https://doi.org/10.1016/S1473-3099(18)30103-8.
2. Sousa LX, Sousa LCO, Cruz JHA et al. Análise epidemiológica da candidemia e espécies fúngicas envolvidas. Archives of Health Investigation, 2020;9:592–595. DOI: https://doi.org/10.21270/archi.v9i6.4830.
3. Cárdenas LL, Merchán MA, López DP New antibiotics against bacterial resistance. Infectio, 2019;23:382. DOI: https://doi.org/10.22354/in.v23i4.807.
4. Feyaerts AF, Mathé L, Luyten W et al. Essential oils and their components are a class of antifungals with potent vapour-phase-mediated anti-Candida activity. Scientific Reports. 2018;8(3958). DOI: https://doi.org/10.1038/s41598-018-22395-6.
5. Piasecki B, Biernasiuk A, Skiba A et al. Composition, Anti-MRSA Activity and Toxicity of Essential Oils from Cymbopogon Species. Molecules. 2021;26:7542. DOI: https://doi.org/10.3390/molecules26247542.
6. Gündel SS, Godoi SN, Santos RCV et al. In vivo antifungal activity of nanoemulsions containing eucalyptus or lemongrass essential oils in murine model of vulvovaginal candidiasis. Journal of Drug Delivery Science and Technology. 2020;57:101762. DOI: https://doi.org/10.1016/j.jddst.2020.101762.
7. Pereira SF, Barroso A, Mourão RHV et al. A Low Energy Approach for the Preparation of Nano-Emulsions with a High Citral-Content Essential Oil. Molecules, 2021;26:3666. DOI: https://doi.org/10.3390/molecules26123666.
8. Mondéjar-López M, Rubio-Maraga A, López-Jimenez A et al. Chitosan nanoparticles loaded with garlic essential oil: A new alternative to tebuconazole as seed dressing agent. Carbohydrate Polymers. 2021;277:118815. DOI: https://doi.org/10.1016/j.carbpol.2021.118815.
9. Patel RP, Joshi JR. An overview on nanoemulsion: a novel approach. International Journal of Pharmaceutical Sciences and Research. 2012. DOI: https://Doi.org/10.13040/ijpsr.0975-8232.3(12).4640-50.
10. Flora e Funga do Brasil. [Internet] 2025 [citado 2025 dez 11]. Disponível em: https://floradobrasil.jbrj.gov.br/FB615065.
11. Giongo JL, Vaucher RA, Fausto VP et al. Anti- Candida activity assessment of Pelargonium graveolens oil free and nanoemulsion in biofilm formation in hospital medical supplies. Microb Pathog. 2016;100:170–178. DOI: https://doi.org/10.1016/j.micpath.2016.08.013.
12. da Costa A, Hott MC, Horn AH. Management of citronella (Cymbopogon winterianus Jowitt ex Bor) for the production of essential oils. SN applied sciences/SN Applied Sciences. 2020;2. DOI: https://doi.org/10.1007/s42452-020-03949-8.
13. Ferreira TM, Silva FS, Teodoro GR et al. Atividade antifúngica do citral em leveduras do gênero Candida isoladas de pacientes hospitalizados. Revista do Instituto Adolfo Lutz. 2009;68:118–125. DOI: https://doi.org/10.53393/rial.2009.68.32751.
14. Gauch LMR, Pedrosa SS, Esteves RA et al. Atividade antifúngica de Rosmarinus officinalis Linn. óleo essencial contra Candida albicans, Candida dubliniensis, Candida parapsilosis e Candida krusei. Revista Pan-Amazônica de Saúde. 2014;5:61–66. DOI: https://doi.org/10.5123/S2176-62232014000100007.
15. Overgaauw AJC, Leeuw DC, Stoof SP et al. Case report: Candida krusei spondylitis in an immunocompromised patient. BMC Infectious Diseases. 2020;20(739). DOI: https://doi.org/10.1186/s12879-020-05451-3.
16. Forim MR, Costa ES, Silva MFGF et al, Development of a New Method To Prepare Nano-/microparticles Loaded with Extracts of Azadirachta indica, Their Characterization and Use in Controlling Plutella xylostella. J Agric Food Chem. 2013;61:9131–9139. DOI: https://doi.org/10.1021/jf403187y.
17. Bolzan AA, Lopes LQ, Marin LS et al. Avaliação da atividade antimicrobiana do óleo de orégano livre e em nanoemulsões. Disciplinarum Scientia. Naturais e Tecnológicas [Internet] 2015 [citado 2025 dez 11];16:325–332. Disponível em: https://periodicos.ufn.edu.br/index.php/disciplinarumNT/article/view/1385.
18. Córdoba S, Vivot W, Szusz W et al. Antifungal Activity of Essential Oils Against Candida Species Isolated from Clinical Samples. Mycopathologia. 2019;184:615–623. DOI: https://doi.org/10.1007/s11046-019-00364-5.
19. Leja K, Drożdżyńska A, Majcher M et al. Influence of sub-inhibitory concentration of selected plant essential oils on the physical and biochemical properties of Pseudomonas orientalis. Open Chemistry, 2019;17:492–505. DOI: https://doi.org/10.1515/chem-2019-0066.
20. Sahal G, Woerdenbag HJ, Hinrichs WLJ et al. Antifungal and biofilm inhibitory effect of Cymbopogon citratus (lemongrass) essential oil on biofilm forming by Candida tropicalis isolates; an in vitro study. Journal of Ethnopharmacology. 2020;246:112188. DOI: https://doi.org/10.1016/j.jep.2019.112188.
Published
Issue
Section
License
Copyright (c) 2026 Dara Monize Pazze, Ketlin Strada, Karine Raquel Uhdich Kleibert, Gabriela Matte Bertoldi, Ivan Ricardo Carvalho, José Antônio Gonzalez Da Silva , Fernanda Wagner Boz, Patrícia Gomes, Giane Engel Montagner, Christiane de Fatima Colet

This work is licensed under a Creative Commons Attribution 4.0 International License.
The author must state that the paper is original (has not been published previously), not infringing any copyright or other ownership right involving third parties. Once the paper is submitted, the Journal reserves the right to make normative changes, such as spelling and grammar, in order to maintain the language standard, but respecting the author’s style. The published papers become ownership of RECI, considering that all the opinions expressed by the authors are their responsibility. Because we are an open access journal, we allow free use of articles in educational and scientific applications provided the source is cited under the Creative Commons CC-BY license.